DOJ alleges parties involved with New York’s CDPAP program mismanaged billing and profit practices, leading to unauthorized Medicaid revenue. The lawsuit is aimed at stopping the ongoing conduct.

In a civil enforcement action, the U.S. Department of Justice moved to stop an alleged Medicaid fraud scheme associated with New York’s Consumer Directed Personal Assistant Program (CDPAP). DOJ said the case involves improper management of program-related billing and profits—conduct DOJ characterizes as driving unauthorized revenue within a program that is heavily supported by federal Medicaid funds. The DOJ announcement describes the lawsuit as targeting ongoing fraud-related practices, including alleged mismanagement by involved parties. DOJ frames the issue as both a compliance and financial integrity problem: fraudulent or improper billing conduct can distort reimbursement and siphon value away from legitimate care delivery. The allegations focus on how profits were handled and how billing practices were administered in ways that purportedly increased unauthorized income. For fraud watchers, the CDPAP case illustrates a common failure point in large benefit programs: complex administrative workflows and reimbursement structures can be exploited when actors manipulate processes to increase payouts. DOJ’s filing signals intent to obtain relief to halt the alleged misconduct and to address the benefits allegedly obtained from the scheme. If proven, the allegations could lead to court-ordered remedies designed to prevent recurrence and correct the financial impact tied to the asserted misconduct.